There is not a specific test to diagnose Alzheimer's disease (AD). Its diagnosis should be based upon clinical history, neuropsychological and laboratory tests, neuroimaging and electroencephalography (EEG). Therefore, new approaches are necessary to enable earlier and more accurate diagnosis and to follow treatment results. In this study we used a Machine Learning (ML) technique, named Support Vector Machine (SVM), to search patterns in EEG epochs to differentiate AD patients from controls. As a result, we developed a quantitative EEG (qEEG) processing method for automatic differentiation of patients with AD from normal individuals, as a complement to the diagnosis of probable dementia. We studied EEGs from 19 normal subjects (14 females/5 males, mean age 71.6 years) and 16 probable mild to moderate symptoms AD patients (14 females/2 males, mean age 73.4 years. The results obtained from analysis of EEG epochs were accuracy 79.9% and sensitivity 83.2%. The analysis considering the diagnosis of each individual patient reached 87.0% accuracy and 91.7% sensitivity.

Recent experimental evidence has suggested a neuromodulatory deficit in Alzheimer's disease (AD). In this paper, we present a new electroencephalogram (EEG) based metric to quantitatively characterize neuromodulatory activity. More specifically, the short-term EEG amplitude modulation rate-of-change (i.e., modulation frequency) is computed for five EEG subband signals. To test the performance of the proposed metric, a classification task was performed on a database of 32 participants partitioned into three groups of approximately equal size: healthy controls, patients diagnosed with mild AD, and those with moderate-to-severe AD. To gauge the benefits of the proposed metric, performance results were compared with those obtained using EEG spectral peak parameters which were recently shown to outperform other conventional EEG measures. Using a simple feature selection algorithm based on area-under-the-curve maximization and a support vector machine classifier, the proposed parameters resulted in accuracy gains, relative to spectral peak parameters, of 21.3% when discriminating between the three groups and by 50% when mild and moderate-to-severe groups were merged into one. The preliminary findings reported herein provide promising insights that automated tools may be developed to assist physicians in very early diagnosis of AD as well as provide researchers with a tool to automatically characterize cross-frequency interactions and their changes with disease.

Background: Affective neurofeedback constitutes a suitable approach to control abnormal neural activities associated with psychiatric disorders and might consequently relief symptom severity. However, different aspects of neurofeedback remain unclear, such as its neural basis, the performance variation, the feedback effect, among others. Aim: First, we aimed to propose a functional near-infrared spectroscopy (fNIRS)-based affective neurofeedback based on the self-regulation of frontal and occipital networks. Second, we evaluated three different feedback approaches on performance: real, fixed, and random feedback. Third, we investigated different demographic, psychological, and physiological predictors of performance. Approach: Thirty-three healthy participants performed a task whereby an amorphous figure changed its shape according to the elicited affect (positive or neutral). During the task, the participants randomly received three different feedback approaches: real feedback, with no change of the classifier output; fixed feedback, keeping the feedback figure unmodified; and random feedback, where the classifier output was multiplied by an arbitrary value, causing a feedback different than expected by the subject. Then, we applied a multivariate comparison of the whole-connectivity profiles according to the affective states and feedback approaches, as well as during a pretask resting-state block, to predict performance. Results: Participants were able to control this feedback system with 70.00% AE 24.43% (p < 0.01) of performance during the real feedback trials. No significant differences were found when comparing the average performances of the feedback approaches. However, the whole functional connectivity profiles presented significant Mahalanobis distances (p ≪ 0.001) when comparing both affective states and all feedback approaches. Finally, task performance was positively correlated to the pretask resting-state whole functional connectivity (r ¼ 0.512, p ¼ 0.009). Conclusions: Our results suggest that fNIRS might be a feasible tool to develop a neurofeedback system based on the self-regulation of affective networks. This finding enables future investigations using an fNIRS-based affective neurofeedback in psychiatric populations. Furthermore, functional connectivity profiles proved to be a good predictor of performance and suggested an increased effort to maintain task control in the presence of feedback distractors.

Abstract-There is recent indication that Alzheimer's disease (AD) can be characterized by atypical modulation of electrophysiological brain activity caused by fibrillar amyloid deposition in specific regions of the brain, such as those related to cognition and memory. In this paper, we propose to objectively characterize EEG sub-band modulation in an attempt to develop an automated noninvasive AD diagnostics tool. First, multi-channel full-band EEG signals are decomposed into five well-known frequency sub-bands: delta, theta, alpha, beta, and gamma. The temporal amplitude envelope of each sub-band is then computed via a Hilbert transformation. The proposed 'spectro-temporal modulation energy' feature measures the rate with which each sub-band is modulated. Modulation energy features are computed for 19 referential EEG signals and seven bipolar signals. Salient features are then selected and used to train four different classifiers, namely, support vector machines, logistic regression, classification and regression trees, and neural networks. Experiments with a database of 34 participants, 22 of which have been clinically diagnosed with probable-AD, show a neural network classifier achieving over 91% accuracy, thus significantly outperforming a classifier trained with conventional spectral-based features.

Major depressive disorder (MDD) is the leading cause of disability worldwide. Neurofeedback training has been suggested as a potential additional treatment option for MDD patients not reaching remission from standard care (i.e., psychopharmacology and psychotherapy). Here we systematically reviewed neurofeedback studies employing electroencephalography, or functional magnetic resonance-based protocols in depressive patients. Of 585 initially screened studies, 24 were included in our final sample (N=480 patients in experimental and N=194 in the control groups completing the primary endpoint). We evaluated the clinical efficacy across studies and explored its relationship with the number of sessions as a potential proxy for a dose-effect response. We also attempted to group studies according to the control condition categories currently used in the field that affect clinical outcomes in group comparisons. In most studies, MDD patients showed symptom improvement superior to the control group(s). However, most articles did not comply with the most stringent study quality and reporting practices. We conclude with recommendations on best practices for experimental designs and reporting standards for neurofeedback training.

No abstract

No abstract

In this paper, an EEG-based biomarker for automated Alzheimer's disease (AD) diagnosis is described, based on extending a recently-proposed "percentage modulation energy" (PME) metric. More specifically, to improve the signal-to-noise ratio of the EEG signal, PME features were averaged over different durations prior to classification. Additionally, two variants of the PME features were developed: the "percentage raw energy" (PRE) and the "percentage envelope energy" (PEE). Experimental results on a dataset of 88 participants (35 controls, 31 with mild-AD and 22 with moderate AD) show that over 98% accuracy can be achieved with a support vector classifier when discriminating between healthy and mild AD patients, thus significantly outperforming the original PME biomarker. Moreover, the proposed system can achieve over 94% accuracy when discriminating between mild and moderate AD, thus opening doors for very early diagnosis.